SCHEMBL3456885

SCHEMBL3456885

Cc1cc2nc(-c3[nH]nc4c3CCN(C(=O)Cc3ccccc3)C4)[nH]c2cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
GPR183 P32249 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
RAB9A P51151 4/20 0.39
HPGD P15428 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 2/20 0.39
TP53 P04637 2/20 0.39
POLB P06746 2/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14032049 0.91 GPBAR1 (0.42) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL14032075 0.87 CYP1A2 (0.54) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL3457136 0.86 MTHFD2 (0.41) NPC1TRPV1RAB9AKDRHPSE
SCHEMBL5067955 0.85 SMN1; SMN2 (0.45) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL3455817 0.85 NPC1 (0.38) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL14032078 0.85 KMT2A (0.40) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL3457565 0.84 KDM4E (0.38) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL3455946 0.84 NPC1 (0.38) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL14032040 0.84 ALDH1A1 (0.42) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C9
SCHEMBL14031876 0.84 HPSE (0.47) NPC1SMN1; SMN2KMT2ACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2251340-A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof Aventis Pharma S.A. (FR) 2010-11-17 EP disclosed
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed
US-7435820-B2 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use AVENTIS PHARMA S.A. (FR) 2008-10-14 US disclosed